Renal safety of Non Steroidal Anti Inflammatory Drugs (NSAIDs) in the pharmacologic treatment of patent ductus arteriosus

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue SUPPL. 1, 2011, Pages 50-52

  Fanos, Vassilios ^a,b   Marcialis, Maria Antonietta ^a,b   Bassareo, Pier Paolo ^b   Antonucci, Roberto ^c   Zaffanello, Marco ^d   Dess, Angelica ^a,b   Iacovidou, Nicoletta ^e  

^a Department of Pediatrics and Clinical Medicine   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c Hospital Nostra Signora di Bonaria   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

^e UNIVERSITY OF ATHENS   (Greece)

Author keywords

Neonates; Nephrotoxicity; Nonsteroidal anti imlammatory drugs; Patent ductus arteriosus

Indexed keywords

ALPHA 1 MICROGLOBULIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DOPAMINE; FUROSEMIDE; IBUPROFEN; INDOMETACIN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; ROFECOXIB;

ACUTE KIDNEY FAILURE; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; DRUG SAFETY; DRUG WITHDRAWAL; GESTATIONAL AGE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERKALEMIA; NEPHROTOXICITY; NONHUMAN; OLIGURIA; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEINURIA; REVIEW; RISK FACTOR; SIDE EFFECT; TERATOGENESIS; URINE VOLUME; DISEASE ASSOCIATION; DRUG EFFICACY; KIDNEY DEVELOPMENT; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; LONG TERM EXPOSURE; MEDICAL LITERATURE; OUTCOME ASSESSMENT; PATIENT CARE; PERITONEAL DIALYSIS; TREATMENT INDICATION; URINARY EXCRETION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG TOXICITY; DUCTUS ARTERIOSUS, PATENT; HUMANS; INFANT, NEWBORN; KIDNEY; KIDNEY DISEASES; ORGANS AT RISK; TIME FACTORS;

EID: 80053221975     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.607593     Document Type: Review

References (25)

1. Aranda JV, Thomas R. Systematic review: Intravenous Ibuprofen in preterm newborns. Semin Perinatol 2006;30:114-120. (Pubitemid 43928131)
2. Fanos V, Cuzzolin L. Causes and manifestations of nephrotoxicity. In: Geary, and Schaefer. (eds.) Clinical Pediatric Nephrology. Mosby Elsevier, 2008.
3. Cataldi L, Leone R, Moretti U, De Mitri B, Fanos V, Ruggeri L, Sabatino G, et al. Potential risk factors for the development of acute renal failure in preterm newborn infants: A case-control study Arch Dis Child Fetal Neonatal Ed 2005 90 F514-F519. (Pubitemid 41565317)
4. Cuzzolin L, Fanos V, Pinna B, di Marzio M, Perin M, Tramontozzi P, Tonetto P, Cataldi L: Postnatal renal function in preterm newborns: A role of diseases, drugs and therapeutic interventions Pediatr Nephrol 2006 21 931-938 (Pubitemid 43885090)
5. Cuzzolin L, Dal Ceré M, Fanos V. NSAID-induced nephrotoxicity from the fetus to the child. Drug Saf 2001;24:9-18. (Pubitemid 32113364)
6. Musu M, Finco G, Antonucci R, Polati E, Sanna D, Evangelista M, Ribuffo D, Schweiger V, Fanos V. Acute nephrotoxicity of NSAID from the fetus to the adult. Eur Rev Med Pharmacol Sci 2011. (In Press).
7. Antonucci R, Cuzzolin L, Arceri A, Fanos V. Urinary prostaglandin E2 in the newborn and infant. Prostaglandins Other Lipid Mediat 2007;84:1-13.
8. Agostiniani R, Mariotti P, Cataldi L, Fanos V, Sani S, Zaccaron A, Cuzzolin L. Role of renal PGE2 in the adaptation from foetal to extrauterine life in term and preterm infants. Prostaglandins Leukot Essent Fatty Acids 2002;67:373-377. (Pubitemid 35398897)
9. Cuzzolin L, Mangiarotti P, Fanos V. Urinary PGE(2) concentrations measured by a new EIA method in infants with urinary tract infections or renal malformations. Prostaglandins Leukot Essent Fatty Acids 2001;64:317-322. (Pubitemid 32695304)
10. Benini D, Fanos V, Cuzzolin L, Tató L. In utero exposure to nonsteroidal anti-inflammatory drugs: Neonatal renal failure. Pediatr Nephrol 2004;19:232-234. (Pubitemid 38181020)
11. Fanos V, Benini D, Verlato G, Errico G, Cuzzolin L. Efficacy and renal tolerability of ibuprofen vs. indomethacin in preterm infants with patent ductus arteriosus. Fundam Clin Pharmacol 2005;19: 187-193. (Pubitemid 40524118)
12. Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2010;CD003481.
13. Vieux R, Desandes R, Boubred F, Semama D, Guillemin F, Buchweiller MC, Fresson J, Hascoet JM. Ibuprofen in very preterm infants impairs renal function for the first month of life. Pediatr Nephrol 2010;25: 267-274. Epub 2009 Nov 10.
14. Antonucci R, Cuzzolin L, Arceri A, Dessí A, Fanos V. Changes in urinary PGE2 after ibuprofen treatment in preterm infants with patent ductus arteriosus. Eur J Clin Pharmacol 2009;65:223-230.
15. Longini M, Perrone S, Vezzosi P, Proietti F, Marzocchi B, Buonocore G, Fanos V, et al Isoprostane levels in urine of preterm newborns treated with ibuprofen for patent ductus arteriosus closure Pediatr Nephrol 2011 26 105-109.
16. Hasan J, Beharry KD, Gharraee Z, Stavitsky Y, Abad-Santos P, Abad-Santos M, Aranda JV, Modanlou HD. Early postnatal ibuprofen and indomethacin effects in suckling and weanling rat kidneys. Prostaglandins Other Lipid Mediat 2008;85:81-88.
17. Sáez F, Reverte V, Salazar F, Castells MT, Llinás MT, Salazar FJ. Hypertension and sex differences in the age-related renal changes when cyclooxygenase-2 activity is reduced during nephrogenesis. Hypertension 2009;53:331-337.
18. Boubred F, Vendemmia M, Garcia-Meric P, Buffat C, Millet V, Simeoni U. Effects of maternally administered drugs on the fetal and neonatal kidney. Drug Saf 2006;29:397-419.
19. Zaffanello M, Brugnara M, Bruno C, Franchi B, Talamini G, Guidi G, Cataldi L, Biban P, Mella R, Fanos V. Renal function and volume of infants born with a very low birth-weight: A preliminary cross-sectional study. Acta Paediatr 2010;99:1192-1198. Epub 2010 Mar 14.
20. Hirt D, Van Overmeire B, Treluyer JM, Langhendries JP, Marguglio A, Eisinger MJ, Schepens P, Urien S. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study Br J Clin Pharmacol 2008 65 629-636. (Pubitemid 351535097)
21. Fanos V, Antonucci R, Zaffanello M. Ibuprofen and acute kidney injury in the newborn. Turk J Pediatr 2010;52:231-238.
22. Atzori L, Antonucci R, Barberini L, Griffin JL, Fanos V. Metabolomics: A new tool for the neonatologist. J Matern Fetal Neonatal Med 2009;22 Suppl 3:50-53.
23. Atzori L, Antonucci R, Barberini L, Locci E, Marincola FC, Scano P, Cortesi P, Agostiniani R, Defraia R, Weljie A, Gazzolo D, Lai A, Fanos V. 1H NMR-based metabolomic analysis of urine from preterm and term neonates. Front Biosci (Elite Ed) 2011;3:1005-1012.
24. Fanos V, Barberini L, Antonucci R, Atzori L. Metabolomics in Neonatology and Pediatrics. Clin Biochemistry 2011;7:452-454.
25. Fanos V, Guimarǎes H. Present and future of European neonatology: Focus on patent ductus arteriosus. J Matern Fetal Neonatal Med 2009;22 Suppl 3:1-2.